Cytoo and Asklepios collaborate to select gene therapy candidate for rare muscle disorder March 3, 2020
Orencia approved for prevention of structural damage of joints in current indication of RA Feb. 24, 2020
Sestrins protect against muscle wasting by coordinating anabolic and catabolic pathways Feb. 11, 2020
Saint Louis University, Indalo Therapeutics patent integrin alphavbeta1/alpha5beta1 antagonists Jan. 29, 2020
RSS